The Pharmaceutical Contract Manufacturing Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
In regard to therapeutic performance and safety characteristics, generic medications are less expensive than their branded counterparts. One of the main factors fueling the demand for generics is the push to lower the rising healthcare expenses. The market entry of various less expensive generic substitutes was made possible by patent expiration. Some of the significant medications whose patents recently expired included Lucentis by Roche, Adasuve by Galen, Perforomist by Mylan, Northera by Lundbeck, and Narcan by Emergent BioSolutions.
Nuclear medicine contract manufacturing also encompasses the development and production of radiopharmaceuticals. Due to recent corporate acquisitions and share offers, interest in the radiopharmaceutical industry has increased. Also, in May 2021, Curium finalized the acquisition of IASON, which aided the firm in growing its service portfolio of life-saving diagnostic solutions and throughout the European market.
In regard to therapeutic performance and safety characteristics, generic medications are less expensive than their branded counterparts. One of the main factors fueling the demand for generics is the push to lower the rising healthcare expenses. The market entry of various less expensive generic substitutes was made possible by patent expiration. Some of the significant medications whose patents recently expired included Lucentis by Roche, Adasuve by Galen, Perforomist by Mylan, Northera by Lundbeck, and Narcan by Emergent BioSolutions.
Nuclear medicine contract manufacturing also encompasses the development and production of radiopharmaceuticals. Due to recent corporate acquisitions and share offers, interest in the radiopharmaceutical industry has increased. Also, in May 2021, Curium finalized the acquisition of IASON, which aided the firm in growing its service portfolio of life-saving diagnostic solutions and throughout the European market.
What Questions Should You Ask before Buying a Market Research Report?
- How is the pharmaceutical contract manufacturing market evolving?
- What is driving and restraining the pharmaceutical contract manufacturing market?
- How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each pharmaceutical contract manufacturing submarket develop from 2022 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading pharmaceutical contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the pharmaceutical contract manufacturing projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of pharmaceutical contract manufacturing projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the pharmaceutical contract manufacturing market?
- Where is the pharmaceutical contract manufacturing market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the pharmaceutical contract manufacturing market today, and over the next 10 years:
- Our 318-page report provides 143 tables, 184 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharmaceutical contract manufacturing prices and recent developments.
Segments Covered in the Report
Services
- Pharmaceutical Manufacturing Services
- Pharmaceutical API Manufacturing Services
- Pharmaceutical FDF Manufacturing Services: Parenteral/Injectable Manufacturing Services, Tablet Manufacturing Services, Capsule Manufacturing Services, Oral Liquid Manufacturing Services, Semi-solid Manufacturing Services, Other Formulation Manufacturing Services
- Drug Development Services
- Lead Identification & Candidate Optimization
- Target Identification & Screening
- Target Validation & Functional Informatics
- Other Services
- Biologics Manufacturing Services
- Biologics API Manufacturing Services
- Biologics FDF Manufacturing Services
Drug Type
- Branded
- Generic
End User
- Big Pharmaceutical Companies
- Small & Medium-sized Pharmaceutical Companies
- Generic Pharmaceutical Companies
- Other End-users
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Switzerland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Leading companies and the potential for market growth
- AbbVie Inc.
- Abnova Corporation
- Aenova Group
- Almac Group
- Baxter
- Boehringer Ingelheim International
- Catalent Inc
- Charles River Laboratories
- Evonik Industries
- Fujifilm Holdings Corporation
- Grifols S.A.
- Jubilant Pharmova Limited
- ICON Plc
- IQVIA
- Lonza
- Nipro Pharma Corporation
- Pfizer Inc.
- Piramal Pharma Solutions
- Recipharm AB
- Samsung Biologics
- Siegfried Holding AG
- Thermo Fisher Scientific
- Vetter Pharma
- WuXi AppTec
How will the Pharmaceutical contract manufacturing Market, 2023 to 2033 report help you?
In summary, this 310+ page report provides you with the following knowledge:- Revenue forecasts to 2033 for pharmaceutical contract manufacturing Market, 2023 to 2033 Market, with forecasts for service, drug type, end-users, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 21 key national markets - See forecasts for the pharmaceutical contract manufacturing Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, China, India, Japan, Australia, South Korea, Brazil, GCC, and South Africa among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the pharmaceutical contract manufacturing Market, 2023 to 2033.
Information found nowhere else
With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the pharmaceutical contract manufacturing Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.Table of Contents
1 Report Overview
3 Market Overview
4 Pharmaceutical Contract Manufacturing Market, by Services, 2023-2033
5 Pharmaceutical Contract Manufacturing Market, by End-users, 2023-2033
6 Pharmaceutical Contract Manufacturing Market, by Drug Type, 2023-2033
7 Pharmaceutical Contract Manufacturing Market Analysis by Region, 2023-2033
8 North America Pharmaceutical Contract Manufacturing Market, 2023-2033
9 Europe Pharmaceutical Contract Manufacturing Market, 2023-2033
10 Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis
11 Latin America Pharmaceutical Contract Manufacturing Market Analysis
12 MEA Pharmaceutical Contract Manufacturing Market Analysis
13 Company Profiles
14 Conclusion and Recommendations
Companies Mentioned
- AbbVie Inc.
- Abnova Corporation
- Aenova Group
- Almac Group
- Baxter
- Boehringer Ingelheim International
- Catalent Inc
- Charles River Laboratories
- Evonik Industries
- Fujifilm Holdings Corporation
- Grifols S.A.
- Jubilant Pharmova Limited
- ICON Plc
- IQVIA
- Lonza
- Nipro Pharma Corporation
- Pfizer Inc.
- Piramal Pharma Solutions
- Recipharm AB
- Samsung Biologics
- Siegfried Holding AG
- Thermo Fisher Scientific
- Vetter Pharma
- WuXi AppTec
- Adare Pharma Solutions
- Adragos Pharma
- Aesica Pharmaceuticals Limited
- Ajinomoto
- Alcami Corporation
- Almac Group
- Asher Biotherapeutics
- Atara Biotherapeutics
- BASF
- Cadila
- CARBOGEN AMCIS
- CDMO Tapemark
- Cenexi Group
- CJP SP Holding, L.P
- Cytiva
- DFE Pharma
- DHS Ventures & Holdings
- Eden Biologics
- Egis
- Eli Lilly and Company
- Emphascience, Inc
- Entos Pharmaceuticals
- Evonik Industries
- Gedeon Richter Pharma
- Gland Pharma
- JRS Pharma
- Jubilant Pharmova Limited
- Kawagoe
- Lipidor
- Lupin
- Merck
- Micro-Sphere
- Nipro Pharma Corporation
- SGS
- Sinovac
- SN BioScience
- Sun Pharmaceutical Industries Ltd
- Sunovion
- Sunsho Pharmaceutical Co., Ltd.
- Takeda
- TCG GreenChem, Inc
- Terumo Pharmaceutical Solutions
- Teva Group
- TWi Pharmaceutical
- Upsher-Smith
- Vector BioMed
- Zentiva
- American Association of Cancer Research
- Association of South Korean Medical Research Institutes
- Agência Nacional de Vigilância Sanitária
- Centre for Drug Evaluation and Research (CDER)
- Centres for Medicare and Medicaid Services (CMS)
- European Medical Agency (EMA)
- Food and Drug Administration (FDA)
- French National Authority for Health
- Global Cancer Observatory (GLOBOCAN)
- International Agency Tor Research on Cancer (IARC)
- National Accrediting Agency report for Clinical Laboratory Sciences
- National Centre for Biotechnology Information
- National Cancer Institute
- World health Organization (WHO)
